NIH #R41GM153041
Developing novel Type 1 CRISPR tools for gene editing therapy
- Amount
- $200K–$300K
- Period
- 2024-02-15 → 2026-01-31
- PIs
- 1
Awarded at GENETOBE INC.
Pluripotent Stem Cells Research · Molecular Biology
Compare more Molecular Biology professors.
1 total · 0 active
NIH #R41GM153041
Awarded at GENETOBE INC.
Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →
Are you this professor?
No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.
Data may not be current
ORCID: 0000-0002-3676-6724